Nursing care
Propylthiouracil: what to check before you give it
Written and reviewed by Dana Whitfield, RN, MSN · 5 min read · Updated September 2026
Short answer
Propylthiouracil (PTU) is an antithyroid drug that blocks thyroid hormone synthesis, used mainly for hyperthyroidism when surgery or radioactive iodine is not an option, including in early pregnancy. The critical nursing consideration is agranulocytosis: any sore throat and fever in a patient on PTU needs a CBC with differential before it is treated as a viral illness.
Why this drug and not another
Propylthiouracil inhibits thyroid peroxidase, blocking the synthesis of T3 and T4, and it also blocks peripheral conversion of T4 to the more active T3 — an effect methimazole does not share. That peripheral action makes PTU the preferred agent in thyroid storm, where rapid reduction of active hormone matters more than convenience of dosing.
PTU is also the preferred antithyroid drug in the first trimester of pregnancy, because methimazole carries a higher risk of a specific congenital malformation pattern (aplasia cutis and other defects) when used in early gestation. Most patients switch to methimazole after the first trimester, because PTU carries a small but serious risk of liver failure with longer use. Methimazole is otherwise preferred for most non-pregnant patients because it is dosed once daily and carries a lower hepatotoxicity risk than PTU.
Administration and timing
PTU is given orally, typically divided into two or three doses a day, unlike methimazole's usual once-daily dosing — this divided schedule reflects its shorter half-life. Give it at the same times each day to maintain steady blood levels, and take it with food if it causes gastric upset, since absorption is not significantly affected by food.
Clinical improvement in hyperthyroid symptoms typically takes several weeks, because the drug blocks new hormone synthesis but does not clear hormone already stored in the thyroid gland. Do not expect or promise rapid symptom relief, and do not increase the dose independently if symptoms persist in the first two to three weeks — that is expected, not treatment failure. Doses are titrated based on periodic thyroid function tests, not on symptoms alone.
Monitoring parameters
Baseline and periodic CBC with differential is the single most important lab to track, because it is the test that catches agranulocytosis before it becomes a life-threatening infection. Liver function tests are checked at baseline and periodically as well, given PTU's black box warning for severe hepatotoxicity, including cases requiring transplant.
Thyroid function tests — TSH, free T4, and sometimes T3 — are monitored every four to six weeks initially to guide dose titration, then less frequently once the patient is euthyroid. Also track clinical signs of both hyper- and hypothyroidism during titration, since over-treatment can push the patient into iatrogenic hypothyroidism just as easily as under-treatment leaves them thyrotoxic.
Adverse effects to report
Agranulocytosis is the adverse effect that defines nursing vigilance on this drug. It can develop abruptly, and the presenting signs are a sore throat and fever — symptoms that look identical to a common cold but, in a patient on PTU, must trigger an urgent CBC with differential rather than reassurance and rest. Teach the patient this distinction explicitly, because they will not otherwise think to mention a sore throat as a medication side effect.
Also report jaundice, dark urine, pale stools, right upper quadrant pain, or unexplained fatigue, which suggest the hepatotoxicity carried in PTU's black box warning and can progress to fulminant liver failure. Rash, joint pain, and unusual bruising or bleeding are additional signs to report, since PTU is also associated with vasculitis and, rarely, ANCA-positive vasculitis with prolonged use. Any of these findings warrants stopping the drug and notifying the provider immediately rather than waiting for the next scheduled visit.
Contraindications and cautions
PTU is contraindicated in patients with an established hypersensitivity to it and used with caution in existing liver disease, given its own hepatotoxic potential. Because it is preferred over methimazole specifically for first-trimester pregnancy, confirm pregnancy status and trimester before assuming either drug is the default choice — the two antithyroid agents are not interchangeable across a pregnancy.
Use caution in patients with existing bone marrow suppression or a history of agranulocytosis on any antithyroid drug, since cross-reactivity with methimazole can occur. PTU crosses into breast milk in smaller amounts than methimazole, which is one reason it is sometimes still favoured during lactation, but coordinate this decision with the prescriber rather than assuming it by default.
Teaching points the exam tests
The teaching point tested most consistently is the sore-throat-and-fever rule: instruct the patient to report these symptoms immediately and to expect a blood test, not reassurance that it is a cold. Reinforce this at every teaching opportunity, because agranulocytosis can develop suddenly even after months of uneventful therapy.
Teach the patient to report jaundice, dark urine, or unusual fatigue as possible liver signs, and to attend all scheduled lab draws even when feeling well, since both agranulocytosis and hepatotoxicity can be silent until symptoms are already serious. Reinforce that improvement takes weeks, not days, and that they should never stop the drug abruptly without provider guidance, since abrupt discontinuation in thyroid storm or unstable hyperthyroidism can precipitate a rebound crisis. Confirm the patient knows the drug's name distinctly from methimazole if they have ever been switched between the two, since dosing schedules differ and mixing them up risks under- or over-treatment.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
What is the priority nursing action if a patient on PTU reports a sore throat and fever?
Obtain a CBC with differential before assuming a viral illness. A sore throat and fever in a patient on propylthiouracil is the classic presentation of agranulocytosis and needs to be ruled out urgently, not treated symptomatically.
Why is PTU used in the first trimester of pregnancy instead of methimazole?
Methimazole carries a higher risk of specific congenital malformations, including aplasia cutis, when used in early pregnancy. PTU is preferred for the first trimester, and most patients are switched to methimazole afterward because PTU carries a greater risk of liver toxicity with longer-term use.
How long does PTU take to work?
Symptom improvement typically takes several weeks, because the drug blocks new hormone synthesis but does not remove hormone already stored in the thyroid gland. Dose adjustments are guided by periodic thyroid function tests rather than by how quickly symptoms resolve.
What labs need to be monitored on propylthiouracil?
CBC with differential to catch agranulocytosis, liver function tests to catch hepatotoxicity, and thyroid function tests every four to six weeks initially to guide dosing. All three are checked at baseline before starting therapy.
Is PTU or methimazole preferred for most patients?
Methimazole is generally preferred for most non-pregnant patients because it is dosed once daily and carries a lower risk of liver toxicity. PTU is reserved for thyroid storm, the first trimester of pregnancy, and patients who cannot tolerate methimazole.